ZELREVV Trademark Information
Number:
2662089
Words:
ZELREVV
Kind:
Word
Status group:
PENDING
Status code:
Accepted
Status detail:
Awaiting publication
Priority date:
26 Mar 2026
Lodgement date:
12 Jun 2026
First report date:
18 Jun 2026
Acceptance date:
18 Jun 2026
Filing date:
12 Jun 2026
Indexing constituents:
ZELREVVClass:
5
Convention details:
Array
Mark categories:
Trademark
Last status check:
2026-06-20 00:49:27
Goods and services:
1) Class: 5Description: Pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, prostate, pancreatic, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders, including castration resistant prostate cancer, Pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, Pharmaceutical preparations for use in the treatment of metastatic diseases, Pharmaceutical preparations for treating metabolic diseases and disorders, Pharmaceutical preparations for treating inflammatory and autoimmune diseases and diseases, Pharmaceutical preparations for treating or preventing cardiovascular and cerebrovascular diseases and disorders, Pharmaceutical preparations.
History and publication details:
1) Date: 2026-06-18
Display name: Early Acceptance Notice correspondence sent
2) Date: 2026-06-18
Display name: Status change to Accepted
3) Date: 2026-06-18
Display name: Awaiting examination
4) Date: 2026-06-18
Display name: Examination expedited
5) Date: 2026-06-12
Display name: IP Right Filed correspondence sent
6) Date: 2026-06-12
Display name: IP Right Filed Published
7) Date: 2026-06-12
Display name: Status change to Published
8) Date: 2026-06-12
Display name: Status change to Filed
9) Date: 2026-06-12
Display name: Minimum Filing Requirements Considered
10) Date: 2026-06-12
Display name: Application Received
11) Date: 2026-06-12
Display name: Status change to Received
12) Date: 2026-06-12
Display name: Trade mark representation updated
Display name: Early Acceptance Notice correspondence sent
2) Date: 2026-06-18
Display name: Status change to Accepted
3) Date: 2026-06-18
Display name: Awaiting examination
4) Date: 2026-06-18
Display name: Examination expedited
5) Date: 2026-06-12
Display name: IP Right Filed correspondence sent
6) Date: 2026-06-12
Display name: IP Right Filed Published
7) Date: 2026-06-12
Display name: Status change to Published
8) Date: 2026-06-12
Display name: Status change to Filed
9) Date: 2026-06-12
Display name: Minimum Filing Requirements Considered
10) Date: 2026-06-12
Display name: Application Received
11) Date: 2026-06-12
Display name: Status change to Received
12) Date: 2026-06-12
Display name: Trade mark representation updated
Owner Information
Owner structured address:
One Amgen Center Drive, Thousand Oaks, CA, UNITED STATES OF AMERICA, Postal Code: 91320-1799
Owner is private:
0
Service Information
Address structured address:
GPO Box 3898, Sydney, NSW, AUSTRALIA, Postal Code: 2001
Address is private:
0